PB Ratio: 8.53

Basis: Latest stored market observation. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 8.53 is 224% above its 5-year average of 2.63, near the low end of its 5-year range (0.87–29.31).

As of Friday, September 4, 2026. 311.80% above its 12-month average of 2.07.

MRNA PB Ratio Metrics

P/B vs. its own history

At 8.53, P/B is above its 8-year median — higher than 77% of readings in its 8-year history.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / Total Shareholders' Equity

The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Moderna, Inc. (MRNA)?

The P/B ratio for MRNA stock is 8.53.

Is Moderna, Inc.'s P/B ratio high or low?

The P/B ratio of 8.53 is 224% above its 5-year average of 2.63, near the low end of its 5-year range (0.87–29.31).

What is the TTM average P/B ratio for Moderna, Inc. (MRNA)?

The TTM average P/B ratio for MRNA stock is 2.07.

What is the 3Y average P/B ratio for Moderna, Inc. (MRNA)?

The 3Y average P/B ratio for MRNA stock is 2.11.

What is the 5Y average P/B ratio for Moderna, Inc. (MRNA)?

The 5Y average P/B ratio for MRNA stock is 2.63.

Showing the most recent 260 of 1,946 data points. The chart above shows the full history.

Related Metrics